Send to a Friend Font Size: Increase Decrease

Viking Global Investors

Viking Global Investors 's Portfolio

Last Updated on 5/16/11 @ 05:55pm

Ticker	# of Shares	Price	Value
	143,085,126	$195.32	$27,947,386,811
	120,000,000	$195.32	$23,438,400,000
	75,238,700	$195.32	$14,695,622,884
GE	7,138,176	$323.11	$2,306,416,048
V	7,140,286	$317.36	$2,266,041,165
	9,798,229	$195.32	$1,913,790,089
MU	4,424,339	$370.30	$1,638,332,732
PM	9,055,492	$169.98	$1,539,252,531
	6,639,199	$195.32	$1,296,768,349
	6,524,565	$195.32	$1,274,378,036
View Additional Portfolio Information »

Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.

Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Mar 7, 2023 07:30AM Cazoo Provides Year-to-Date Business Performance Update
Mar 3, 2023 09:41AM Form D/A Viking Global Equities
Mar 3, 2023 09:40AM Form D/A Viking Global Equities
Mar 3, 2023 09:38AM Form D/A Viking Global Equities
Feb 27, 2023 05:11PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Feb 22, 2023 04:16PM Cazoo (CZOO) Sells Cazana Data Platform
Feb 22, 2023 04:15PM Cazoo Sells Cazana Data Platform
Feb 17, 2023 09:00AM Cazoo (CZOO) Agrees Sale of German Subscription Business
Feb 17, 2023 09:00AM Cazoo Agrees Sale of German Subscription Business
Feb 14, 2023 03:38PM Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
Feb 14, 2023 01:19PM Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Trevi Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Amylyx Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Guardant Health, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A Pharvaris N.V. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A APi Group Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:19PM Form SC 13G/A FIGS, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A PROCEPT BioRobotics Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Orion Acquisition Corp. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Coupa Software Inc Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Celldex Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2023 01:18PM Form SC 13G/A STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Feb 7, 2023 04:13PM Cazoo (CZOO) Announces Reverse Stock Split and Increase in Authorized Share Capital
Feb 7, 2023 04:10PM Cazoo Announces Reverse Stock Split and Increase in Authorized Share Capital
Jan 31, 2023 07:30AM Biomanufacturing Company Vector BioMed Launches with Mission to Provide Access to High-Quality Lentiviral Vectors and Address the Vector Supply Bottleneck
Jan 26, 2023 06:00AM Pearl Health raises $75M Series B led by a16z to accelerate growth and innovation in value-based care
Jan 22, 2023 07:02PM Top hedge funds earned sharply less for clients in 2022, LCH data shows
Jan 19, 2023 08:00AM SetPoint Medical Announces $80M Preferred Stock Financing to Advance Company’s Novel Treatment for Autoimmune Diseases
Jan 18, 2023 06:32AM Cazoo (CZOO) Reports Prelim Q4 Results, Revises 2023 Guidance
Jan 18, 2023 06:30AM Cazoo Announces Fourth Quarter 2022 Preliminary Financial Results and Revised 2023 Plan
Jan 17, 2023 10:18AM Battelle, Viking Global Investors Launch Revive Environmental™
Jan 6, 2023 07:00AM Form D/A Viking Global Opportunit
Jan 6, 2023 06:55AM Form D/A Viking Global Opportunit
Jan 5, 2023 09:01AM Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines
Jan 4, 2023 09:00AM Mantra Bio Raises $9 Million in Series A-2 Financing to Advance Development of Lead Targeted Exosome Therapeutics Program
Dec 15, 2022 10:37AM Tourmaline Partners Adds Industry Veteran Matt Ney to Trading Team
Dec 15, 2022 08:30AM Patina announces partnerships with major national Medicare Advantage plans, significantly expanding the reach of its unique primary care experience for adults 65+ in Philadelphia region
Dec 15, 2022 08:05AM Cazoo (CZOO) Sells Its Spanish Subscription Business
Dec 15, 2022 08:00AM Cazoo Sells Its Spanish Subscription Business
Dec 12, 2022 08:02AM Whole Earth Brands (FREE) Announces CEO Transition Plan
Dec 12, 2022 08:00AM Whole Earth Brands, Inc. Announces CEO Transition Plan
Nov 25, 2022 01:44PM Form SC 13D/A Frazier Lifesciences Filed by: VIKING GLOBAL INVESTORS LP
Nov 14, 2022 04:19PM Form 13F-HR VIKING GLOBAL INVESTORS For: Sep 30
Nov 10, 2022 04:57PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Nov 10, 2022 08:01AM Cazoo (CZOO) Noteholders Voluntarily Extend Lock-Up Period
Nov 10, 2022 08:00AM Cazoo Noteholders Voluntarily Extend Lock-Up Period
Nov 3, 2022 05:13PM Form SC 13D Frazier Lifesciences Filed by: VIKING GLOBAL INVESTORS LP

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed